Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AutoLITT™ FIM Trial - A Prospective First-In-Man (FIM) Safety Trial of the AutoLITT Laser Treatment of Recurrent/Progressive Brain Tumors

NCT00747253 is registered in ClinicalTrials.gov with Monteris Medical as lead sponsor.

NCT NCT00747253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00747253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AutoLITT™ FIM Trial - A Prospective First-In-Man (FIM) Safety Trial of the AutoLITT Laser Treatment of Recurrent/Progressive Brain Tumors
Lead sponsor
Monteris Medical
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2008
Completion date
April 30, 2010
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer, brain neoplasm, brain tumor, brain tumor, recurrent, glioblastoma multiforme, recurrent glioblastoma multiforme